Nishigaki Tetsuta, Tanaka Katsushi, Kawasaki Rika, Hashiguchi Shunta, Kato Hideaki
Pharmaceutical Department, Yokohama City University Hospital, Yokohama, JPN.
Respiratory Medicine, Yokohama City University Hospital, Yokohama, JPN.
Cureus. 2024 Oct 11;16(10):e71250. doi: 10.7759/cureus.71250. eCollection 2024 Oct.
species are associated with healthcare-associated infections, specifically in device implantation. Here, we report a rare case of a 44-year-old man with a totally implantable central venous access port-related infection. When he developed a fever on day four of admission, vancomycin treatment was initiated. On the 11th day, the totally implantable central venous access port was removed. was identified from two sets of blood cultures. Vancomycin treatment was continued for 14 days after port removal, and the patient was discharged home on the 47th day. Although infection had not been previously reported in humans, it could be treated by port removal and vancomycin administration, as demonstrated in other reports on infections.
某些物种与医疗保健相关感染有关，特别是在设备植入方面。在此，我们报告一例罕见病例，一名44岁男性发生了与完全植入式中心静脉通路端口相关的感染。他在入院第4天出现发热时，开始使用万古霉素治疗。第11天，移除了完全植入式中心静脉通路端口。从两组血培养中鉴定出[具体菌种未给出]。端口移除后继续使用万古霉素治疗14天，患者于第47天出院回家。尽管[具体菌种未给出]感染此前尚未在人类中报道过，但正如其他关于[具体菌种未给出]感染的报告所示，通过移除端口和给予万古霉素可以对其进行治疗。
